To do a good job, you have to take care of yourself first.
Release time:
2020-08-14
To do a good job, you must first manage yourself
. Freedom and success are what everyone yearns for, but no one can enjoy completely unprincipled freedom; if you want to achieve real success, You must also follow certain rules, such as laws, principles, discipline, etc., otherwise, even if you can enjoy unlimited scenery for a while, you will eventually fall from the clouds. If you want to find a suitable fit between freedom and constraint, the first thing to do is to "manage yourself". In manufacturing-oriented enterprises such as Jianfeng, "self-management" and "self-restraint" are particularly important. 4# June 8 , the party committee of the group company held a special meeting. all party committee members and senior executives earnestly criticized and self-criticized, which is a concrete manifestation of strengthening "self-management.
If you want to do a good job, you must first manage yourself. Only in this way can you show initiative and planning, and have the confidence and courage to meet challenges and overcome setbacks. There has never been a shortage of capable people in the world, but the ability may not be able to achieve success, or may not be able to achieve the expected success. The reason is mostly because they lack the understanding of "self-management. As far as the team is concerned, if everyone can't abide by the rules and discipline and self-discipline, even if every team member has a strong ability, it will only be a mess. In terms of management, if managers cannot manage themselves well and do not have enough prestige and cohesion, they are bound to fall into an embarrassing situation that makes it difficult to implement and ban. Personally, if you can't manage yourself well, you can't let leaders rest assured and colleagues trust you, even if it is difficult to do a good job in this post, how can we succeed?
Young people are the main force and hope for the future of the peak business. For this reason, the company has a wide range of talents and talents every year. For the newly recruited college and secondary school students, especially the graduates who have just left the school, before they can take on the important work independently, they should first practice "self-management". Last month, why did the group company give a career planning course to employees with college and secondary education who have been employed in the past three years? Because over the years, the company has opened up a stage and development channel for employees to show their talents through a series of talent management and incentive systems, such as the selection of reserve talents and the evaluation of job qualifications. at the company level, the "door" of employees' career development has been opened wider and wider, and then it has come to the link of "practice depends on individuals. The process of personal "practice" is self-planning and self-learning, that is, "self-management". In other words, only by managing yourself can you get closer and closer to personal success.
In our daily work, there are also many cases of unprincipled "releasing ourselves" causing evil consequences. The most common one is habitual violation in production. Among the parties involved in safety accidents over the years, there are many experienced old employees who are familiar with the rules and regulations and operating procedures. When they encounter problems, they do not "manage themselves" because of fluke psychology and convenience, causing losses to the enterprise and causing injuries to themselves. Why bother?
Famous entrepreneur Dong Mingzhu's key to success is only one sentence, "Be hard on yourself". To put it bluntly, "being cruel to yourself" means having high standards and strict requirements on yourself, that is, actively managing and restraining yourself. Therefore, the employees who can manage their own employees well are the employees who can be responsible for the enterprise and themselves, the employees who can promote the healthy development of the enterprise, and the employees who are most welcomed by the enterprise and colleagues. (Hong Tao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page